Genelux Corporation
GNLX • NASDAQ • Stock Fundamentals
Genelux Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas D. Zindrick, with a market cap of $129.1M.
Market Cap$129.1M
Employees23.0
CEOThomas D. Zindrick
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Genelux Corporation FAQ
Common questions about Genelux Corporation
Genelux Corporation (GNLX) has a market capitalization of $129.1M and trades on NASDAQ.
Genelux Corporation has approximately 23 employees.